Use of activated protein c in liver tran
✍
Laura Rinaldi; Marco Marietta; Mariano Alejandro Mignini; Lara Donno; Stefano Bu
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 82 KB
Recombinant human activated protein C (rhAPC) has been approved for use in patients with severe sepsis at high risk of death. Because of the high risk of bleeding, liver transplantation (LT) patients have been excluded from the randomized control trials that evaluated efficacy and safety of rhAPC an